US Pharma MarketingCEO Kevin Lobo said the attack had a “big impact” on first-quarter results. However, the company maintained its full-year guidance.
Stryker cyberattack ‘meaningfully’ impacted Q1
<figure><div><img src="https://imgproxy.divecdn.com/4gQBQ_4pgZA16ab4dxbwcG5FnFvNWHyE_q_FgS5JP1E/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS8yVEMzQU5NLmpwZw==.webp"/></div></figure><p>CEO Kevin Lobo said the attack had a “big impact” on first-quarter results. However, the company maintained its full-year guidance.</p>
Source: MedTech Dive